BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35862303)

  • 1. A cardiac-null mutation of Prdm16 causes hypotension in mice with cardiac hypertrophy via increased nitric oxide synthase 1.
    Kang JO; Ha TW; Jung HU; Lim JE; Oh B
    PLoS One; 2022; 17(7):e0267938. PubMed ID: 35862303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac-specific inactivation of
    Nam JM; Lim JE; Ha TW; Oh B; Kang JO
    Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H764-H777. PubMed ID: 32083975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prdm16 Deficiency Leads to Age-Dependent Cardiac Hypertrophy, Adverse Remodeling, Mitochondrial Dysfunction, and Heart Failure.
    Cibi DM; Bi-Lin KW; Shekeran SG; Sandireddy R; Tee N; Singh A; Wu Y; Srinivasan DK; Kovalik JP; Ghosh S; Seale P; Singh MK
    Cell Rep; 2020 Oct; 33(3):108288. PubMed ID: 33086060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prdm16 mutation determines sex-specific cardiac metabolism and identifies two novel cardiac metabolic regulators.
    Kühnisch J; Theisen S; Dartsch J; Fritsche-Guenther R; Kirchner M; Obermayer B; Bauer A; Kahlert AK; Rothe M; Beule D; Heuser A; Mertins P; Kirwan JA; Berndt N; MacRae CA; Hubner N; Klaassen S
    Cardiovasc Res; 2024 Feb; 119(18):2902-2916. PubMed ID: 37842925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRDM16 Is a Compact Myocardium-Enriched Transcription Factor Required to Maintain Compact Myocardial Cardiomyocyte Identity in Left Ventricle.
    Wu T; Liang Z; Zhang Z; Liu C; Zhang L; Gu Y; Peterson KL; Evans SM; Fu XD; Chen J
    Circulation; 2022 Feb; 145(8):586-602. PubMed ID: 34915728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in beta-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat.
    Bendall JK; Damy T; Ratajczak P; Loyer X; Monceau V; Marty I; Milliez P; Robidel E; Marotte F; Samuel JL; Heymes C
    Circulation; 2004 Oct; 110(16):2368-75. PubMed ID: 15466641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined loss of neuronal and endothelial nitric oxide synthase causes premature mortality and age-related hypertrophic cardiac remodeling in mice.
    Barouch LA; Cappola TP; Harrison RW; Crone JK; Rodriguez ER; Burnett AL; Hare JM
    J Mol Cell Cardiol; 2003 Jun; 35(6):637-44. PubMed ID: 12788381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of cardiac NOS due to endotoxemia and vagal overactivity contributes to the hypotensive effect of chronic ethanol in female rats.
    El-Mas MM; Fan M; Abdel-Rahman AA
    Eur J Pharmacol; 2011 Jan; 650(1):317-23. PubMed ID: 20970417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of angiotensin II and l-NG-nitroarginine methyl ester exacerbates mitochondrial dysfunction and oxidative stress to cause heart failure.
    Hamilton DJ; Zhang A; Li S; Cao TN; Smith JA; Vedula I; Cordero-Reyes AM; Youker KA; Torre-Amione G; Gupte AA
    Am J Physiol Heart Circ Physiol; 2016 Mar; 310(6):H667-80. PubMed ID: 26747502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced neuronal nitric oxide synthase expression contributes to cardiac oxidative stress and nitroso-redox imbalance in ob/ob mice.
    Saraiva RM; Minhas KM; Zheng M; Pitz E; Treuer A; Gonzalez D; Schuleri KH; Vandegaer KM; Barouch LA; Hare JM
    Nitric Oxide; 2007 May; 16(3):331-8. PubMed ID: 17307368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aerobic exercise protects against pressure overload-induced cardiac dysfunction and hypertrophy via β3-AR-nNOS-NO activation.
    Wang B; Xu M; Li W; Li X; Zheng Q; Niu X
    PLoS One; 2017; 12(6):e0179648. PubMed ID: 28622359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure.
    Zhang P; Xu X; Hu X; van Deel ED; Zhu G; Chen Y
    Circ Res; 2007 Apr; 100(7):1089-98. PubMed ID: 17363700
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Kramer RJ; Fatahian AN; Chan A; Mortenson J; Osher J; Sun B; Parker LE; Rosamilia MB; Potter KB; Moore K; Atkins SL; Rosenfeld JA; Birjiniuk A; Jones E; Howard TS; Kim JJ; Scott DA; Lalani S; Rouzbehani OMT; Kaplan S; Hathaway MA; Cohen JL; Asaki SY; Martinez HR; Boudina S; Landstrom AP
    Circ Genom Precis Med; 2023 Aug; 16(4):390-400. PubMed ID: 37395136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of VASP phosphorylation in cardiac myocytes: differential regulation by cyclic nucleotides and modulation of protein expression in diabetic and hypertrophic heart.
    Sartoretto JL; Jin BY; Bauer M; Gertler FB; Liao R; Michel T
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1697-710. PubMed ID: 19734360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsense Variant PRDM16-Q187X Causes Impaired Myocardial Development and TGF-β Signaling Resulting in Noncompaction Cardiomyopathy in Humans and Mice.
    Sun B; Rouzbehani OMT; Kramer RJ; Ghosh R; Perelli RM; Atkins S; Fatahian AN; Davis K; Szulik MW; Goodman MA; Hathaway MA; Chi E; Word TA; Tunuguntla H; Denfield SW; Wehrens XHT; Whitehead KJ; Abdelnasser HY; Warren JS; Wu M; Franklin S; Boudina S; Landstrom AP
    Circ Heart Fail; 2023 Dec; 16(12):e010351. PubMed ID: 38113297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal nitric oxide synthase is indispensable for the cardiac adaptive effects of exercise.
    Roof SR; Tang L; Ostler JE; Periasamy M; Györke S; Billman GE; Ziolo MT
    Basic Res Cardiol; 2013 Mar; 108(2):332. PubMed ID: 23377961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eplerenone prevents adverse cardiac remodelling induced by pressure overload in atrial natriuretic peptide-null mice.
    Franco V; Chen YF; Feng JA; Li P; Wang D; Hasan E; Oparil S; Perry GJ
    Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):773-9. PubMed ID: 16922805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of neuronal nitric oxide synthase increases mortality and cardiac remodeling after myocardial infarction: role of nitroso-redox equilibrium.
    Saraiva RM; Minhas KM; Raju SV; Barouch LA; Pitz E; Schuleri KH; Vandegaer K; Li D; Hare JM
    Circulation; 2005 Nov; 112(22):3415-22. PubMed ID: 16301341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collecting duct-derived endothelin regulates arterial pressure and Na excretion via nitric oxide.
    Schneider MP; Ge Y; Pollock DM; Pollock JS; Kohan DE
    Hypertension; 2008 Jun; 51(6):1605-10. PubMed ID: 18391099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.